AMERISAFE stock
AMSFNASDAQAMERISAFE, Inc., Financial ServicesISIN US03071H1005
58Score 58 out of 100, Neutral
Price and trend
24 / 100
Price history
−53% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 36% below it.
Since April 2025 the 50-day line has been below the 200-day line; the trend has turned down.
Sharply down: the price has fallen very quickly lately (RSI 4).
The price is 54% below its 52-week high. Largest decline in 20 years: 75% (February 2020 to November 2026).
Chart figures for advanced users
- SMA 50$23.78
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$30.11
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)4
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$19.31
- The lowest closing price of the last twelve months.
- Resistance$41.57
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- AMERISAFE, Inc. belongs to the Insurance (Specialty) industry (United States) and, with a market value of $358.06M, is number 13 of 13 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $317.25M (up 2.6% year on year) and earnings of $47.15M (down 15%).
- MEQIRI Score 58 out of 100 (Neutral): rank 760 of 976 in Financial Services, median 68.
Show more
- The P/E is 8.9 (Insurance (Specialty) median 9.4, own median of recent years 15.4).
- Our model puts fair value at $29.16, with the price 34% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- High dividend yieldDividend yield 8.44%, Insurance (Specialty) median 2.48%.Capital allocation 77
- High return on equityReturn on equity 16.4% over the last 12 months.Profitability 73
- Reliable dividendNo dividend cut for 13 years.Capital allocation 77
Weaknesses
- Share price fell sharplyDown 53% over the last 12 months.Momentum 12
- Margin fallingOperating margin 18.6%, average of the prior years 25.1% (to 2024).
- Earnings per share fallingDown 11.2% a year since 2020.Growth 17
Its standout strengths are valuation and fundamentals, while growth and momentum hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
The fundamentals are strong overall.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among smaller stocks.
From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- price far below its 52-week high
- weak momentum
- weak chart
What lowers it
- solid fundamentals
- price not overheated over the past year
- low growth grade (crashed less often in the backtest)
Valuation
Valuation signal
Possible value trapClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $22.43 and expensive above $41.66 (uncertainty medium, based on the price swings of the past year).
The two parts of the fair value come to $37.95 (excess return model) and $20.37 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.
Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $26.00, at 7.8% it would be $33.91.
Possible value trap: looks cheap, but weak growth.
Valuation metrics
Half from the excess return model, half from earnings times the industry P/E (9.4).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 7.7% on the twelve months before. Revenue has stayed largely stable since 2006.
Margins
- Operating margin
- Net margin
In fiscal 2025: operating 19%, net 15%. Banks and insurers have no gross margin, and their net margin is not comparable with other industries. The score leaves both out.
Debt & balance sheet
latest quarterFor banks and insurers, deposits and liabilities are the business. Debt to equity and the current ratio say little here, and the score does not rate them.
Earnings
- Next earnings
- 24 Feb 2027in 104 days
- Last reported
- 28 Oct 2026EPS reported $0.40 (expected $0.48)below expectations
Analyst estimates
- Earnings per share
- $1.88−4.3%
- Revenue
- $328.25M−1.5%
- Earnings per share
- $1.88−6.8%
- Revenue
- $340.57M−2.6%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: −17.4%AMERISAFE reaffirms its target of mid-single-digit growth for the year, despite increased competition and ongoing declines in loss costs.
The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 29 Oct 2026 (fiscal Q3 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases or sales in the last 6 months.
- Omiridis AnastasiosSale
20 Nov 2025, EVP-CFO
- Shares
- 1,247
- Price
- $40.21
- Value
- $50,142
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at AMERISAFE
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
976 rated companies in Financial Services
- This company
- 58
- Sector median
- 68
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Insurance (Specialty)
The next larger companies by market value
- MGIC InvestmentMTG $5.54B73
- Radian GroupRDN $4.71B75
- Assured GuarantyAGO $3.24B57
- NMI HoldingsNMIH $2.94B72
- CofaceCOFA.PA $2.69B70
- Employers HoldingsEIG $830.05M53
- TiptreeTIPT $642.18M54
- Investors TitleITIC $497.13M62
ETFs that hold AMERISAFE
Held by 11 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| L&G Russell 2000 US Small Cap Quality UCITS ETFETLZ | 0.02% | 0.30% | €185.82M |
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.02% | 0.30% | €4.22B |
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.01% | 0.30% | €2.17B |
Show 5 more
| State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETFZPRV | 0.01% | 0.30% | €944.34M |
| iShares MSCI World Small Cap UCITS ETFIUSN | 0.01% | 0.35% | €8.19B |
| iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETFCBUG | 0.01% | 0.35% | €434.1M |
| Avantis Global Small Cap Value UCITS ETFAVWS | 0.01% | 0.39% | €1.47B |
| iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETFSXRG | 0.00% | 0.43% | €2.48B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 6 Dec 2024)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.